Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors

Journal of Cancer Epidemiology

Volumn 2013, Issue , 2013, Pages

  Pellegriti, Gabriella ^a   Frasca, Francesco ^b   Regalbuto, Concetto ^b   Squatrito, Sebastiano ^b   Vigneri, Riccardo ^c  

^a Garibaldi Nesima Hospital   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Garibaldi Nesima Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; IODINE; THYROTROPIN;

BIRTH; BODY WEIGHT; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIETARY INTAKE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; HASHIMOTO DISEASE; HUMAN; INDUSTRIALIZATION; INSULIN RESISTANCE; LIFESTYLE; OBESITY; POLLUTION; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SEX DIFFERENCE; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROTROPIN BLOOD LEVEL;

EID: 84878638727     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2013/965212     Document Type: Review

References (83)

1. Curado M. P., Edwards B., Shin H. R., Storm H., Ferlay J., Heanue M., P M. B., Cancer Incidence in Five Continents 2007 9 No. 160 Lyon, France IARC IARC Scientific Publications
2. Kilfoy B. A., Zheng T., Holford T. R., Han X., Ward M. H., Sjodin A., Zhang Y., Bai Y., Zhu C., Guo G. L., Rothman N., Zhang Y., International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes and Control 2009 20 5 525 531 2-s2.0-66649112355 10.1007/s10552-008-9260-4
3. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010. CA: A Cancer Journal for Clinicians 2010 60 5 277 300 2-s2.0-77955635233 10.3322/caac.20073
4. dal Maso L., Lise M., Zambon P., Falcini F., Crocetti E., Serraino D., Cirilli C., Zanetti R., Vercelli M., Ferretti S., Stracci F., de Lisi V., Busco S., Tagliabue G., Budroni M., Tumino R., Giacomin A., Franceschi S., Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects. Annals of Oncology 2011 22 4 957 963 10.1093/annonc/mdq467
5. Aschebrook-Kilfoy B., Kaplan E. L., Chiu B. C., Angelos P., Grogan R. H., The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Annals of Surgical Oncology 2013 10.1245/s10434-013-2892-y
6. Enewold L., Zhu K., Ron E., Marrogi A. J., Stojadinovic A., Peoples G. E., Devesa S. S., Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiology Biomarkers and Prevention 2009 18 3 784 791 2-s2.0-64549114616 10.1158/1055-9965.EPI-08- 0960
7. Kent W. D. T., Hall S. F., Isotalo P. A., Houlden R. L., George R. L., Groome P. A., Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. Canadian Medical Association Journal 2007 177 11 1357 1361 2-s2.0-36749016190 10.1503/cmaj.061730 (Pubitemid 350207190)
8. Davies L., Welch H. G., Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 2006 295 18 2164 2167 2-s2.0-33646442046 10.1001/jama.295.18.2164
9. Grodski S., Brown T., Sidhu S., Gill A., Robinson B., Learoyd D., Sywak M., Reeve T., Delbridge L., Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 2008 144 6 1038 1043 2-s2.0-56449093385 10.1016/j.surg.2008.08.023
10. Rego-Iraeta A., Pérez-Méndez L. F., Mantinan B., Garcia-Mayor R. V., Time trends for thyroid cancer in northwestern spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 2009 19 4 333 340 2-s2.0-66749088013 10.1089/thy.2008.0210
11. Simard E. P., Ward E. M., Siegel R., Jemal A., Cancers with increasing incidence trends in the United States: 1999 through 2008. CA: A Cancer Journal For Clinicians 2012 62 2 118 128 10.3322/caac.20141
12. Chen A. Y., Jemal A., Ward E. M., Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009 115 16 3801 3807 2-s2.0-68549099879 10.1002/cncr.24416
13. Aschebrook-Kilfoy B., Ward M. H., Sabra M. M., Devesa S. S., Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011 21 2 125 134 2-s2.0-79953237137 10.1089/thy.2010.0021
14. Welch H. G., Albertsen P. C., Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. Journal of the National Cancer Institute 2009 101 19 1325 1329 2-s2.0-70349941075 10.1093/jnci/djp278
15. Schlumberger M., Borget I., Nascimento C., Brassard M., Leboulleux S., Treatment and follow-up of low-risk patients with thyroid cancer. Nature Reviews Endocrinology 2011 7 10 625 628 10.1038/nrendo.2011.133
16. Ito Y., Miyauchi A., Is surgery necessary for papillary thyroid microcarcinomas? Nature Reviews Endocrinology 2012 8 1 9
17. Alexander E. K., Larsen P. R., Radioiodine for thyroid cancer-is less more? The New England Journal of Medicine 2012 366 18 1732 1733 10.1056/NEJMe1202172
18. Schlumberger M., Catargi B., Borget I., Deandreis D., Zerdoud S., Bridji B., Bardet S., Leenhardt L., Bastie D., Schvartz C., Vera P., Morel O., Benisvy D., Bournaud C., Bonichon F., Dejax C., Toubert M. E., Leboulleux S., Ricard M., Benhamou E., Strategies of radioiodine ablation in patients with low-risk thyroid cancer. The New England Journal of Medicine 2012 366 18 1663 1673
19. Pellegriti G., Scollo C., Lumera G., Regalbuto C., Vigneri R., Belfiore A., Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. Journal of Clinical Endocrinology and Metabolism 2004 89 8 3713 3720 2-s2.0-4043142722 10.1210/jc.2003-031982 (Pubitemid 39071462)
20. Aschebrook-Kilfoy B., Grogan R., Ward M., Kaplan E., Devesa S., Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid 2013 10.1089/thy.2012.0356
21. Mazzaferri E. L., Management of a solitary thyroid nodule. The New England Journal of Medicine 1993 328 8 553 559 2-s2.0-0027465843 10.1056/NEJM199302253280807 (Pubitemid 23053833)
22. Nilsson I. L., Arnberg F., Zedenius J., Sundin A., Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm. World Journal of Surgery 2011 35 12 2691 2697 10.1007/s00268-011-1291-4
23. 18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factor. Journal of Clinical Endocrinology and Metabolism 2010 95 7 3182 3188 2-s2.0-77954890772 10.1210/jc.2009-2091
24. Sprague B. L., Warren Andersen S., Trentham-Dietz A., Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes and Control 2008 19 6 585 593 2-s2.0-46449105188 10.1007/s10552-008-9122-0
25. Harach H. R., Franssila K. O., Wasenius V. M., Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 1985 56 3 531 538 2-s2.0-0021809472 (Pubitemid 15035581)
26. Mazzaferri E. L., Managing thyroid microcarcinomas. Yonsei Medical Journal 2012 53 1 1 14 10.3349/ymj.2012.53.1.1
27. Haggar F. A., Preen D. B., Pereira G., Holman C. D., Einarsdottir K., Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007. BMC Cancer 2012 12 1 151 10.1186/1471-2407-12-151
28. Liu S., Semenciw R., Ugnat A. M., Mao Y., Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. British Journal of Cancer 2001 85 9 1335 1339 2-s2.0-0035798459 10.1054/bjoc.2001.2061 (Pubitemid 33085531)
29. Ellison L. F., Wilkins K., Canadian trends in cancer prevalence. Health Reports 2012 23 1 7 16
30. Wang Y., Wang W., Increasing incidence of thyroid cancer in shanghai, China, 1983-2007. Asia-Pacific Journal of Public Health 2012 10.1038/npre.2011.5994.1
31. Colonna M., Guizard A. V., Schvartz C., Velten M., Raverdy N., Molinie F., Delafosse P., Franc B., Grosclaude P., A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). European Journal of Cancer 2007 43 5 891 900 2-s2.0-33847650900 10.1016/j.ejca.2006.11.024 (Pubitemid 46366691)
32. Mathur A., Moses W., Rahbari R., Khanafshar E., Duh Q. Y., Clark O., Kebebew E., Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer 2011 117 19 4390 4395 10.1002/cncr.26072
33. Romei C., Fugazzola L., Puxeddu E., Frasca F., Viola D., Muzza M., Moretti S., Luisa Nicolosi M., Giani C., Cirello V., Avenia N., Rossi S., Vitti P., Pinchera A., Elisei R., Modifications in the papillary thyroid cancer gene profile over the last 15 years. The Journal of Clinical Endocrinology & Metabolism 2012 97 9 E1758 E1765
34. Zhu C., Zheng T., Kilfoy B. A., Han X., Ma S., Ba Y., Bai Y., Wang R., Zhu Y., Zhang Y., A birth cohort analysis of the incidence of papillary thyroid cancer in the united states, 1973-2004. Thyroid 2009 19 10 1061 1066 2-s2.0-70350651449 10.1089/thy.2008.0342
35. Mettler F. A. Jr., Bhargavan M., Thomadsen B. R., Gilley D. B., Lipoti J. A., Mahesh M., McCrohan J., Yoshizumi T. T., Nuclear Medicine Exposure in the United States, 2005-2007: preliminary results. Seminars in Nuclear Medicine 2008 38 5 384 391 2-s2.0-47749137784 10.1053/j.semnuclmed.2008.05.004 (Pubitemid 352033561)
36. Mettler F. A. Jr., Wiest P. W., Locken J. A., Kelsey C. A., CT scanning: patterns of use and dose. Journal of Radiological Protection 2000 20 4 353 359 2-s2.0-0034529475 10.1088/0952-4746/20/4/301 (Pubitemid 32015689)
37. Linton O. W., Mettler F. A., National conference on dose reduction in CT, with an emphasis on pediatric patients. American Journal of Roentgenology 2003 181 2 321 329 2-s2.0-0042845953 (Pubitemid 36909472)
38. Baker S. R., Bhatti W. A., The thyroid cancer epidemic: is it the dark side of the CT revolution? European Journal of Radiology 2006 60 1 67 69 2-s2.0-33748787694 10.1016/j.ejrad.2006.04.022 (Pubitemid 44404159)
39. Williams D., Radiation carcinogenesis: lessons from Chernobyl. Oncogene 2008 27 supplement 2 S9 S18 2-s2.0-72949120662 10.1038/onc.2009.349
40. Pearce M. S., Salotti J. A., Little M. P., McHugh K., Lee C., Kim K. P., Howe N. L., Ronckers C. M., Rajaraman P., Craft A. W., Parker L., Berrington de Gonzalez A., Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. The Lancet 2012 380 9840 499 4505 10.1016/S0140-6736(12)60815-0
41. Mazonakis M., Tzedakis A., Damilakis J., Gourtsoyiannis N., Thyroid dose from common head and neck CT examinations in children: is there an excess risk for thyroid cancer induction? European Radiology 2007 17 5 1352 1357 2-s2.0-34247891691 10.1007/s00330-006-0417-9 (Pubitemid 46691966)
42. Berrington de González A., Mahesh M., Kim K. P., Bhargavan M., Lewis R., Mettler F., Land C., Projected cancer risks from computed tomographic scans performed in the United States in 2007. Archives of Internal Medicine 2009 169 22 2071 2077 2-s2.0-73149113560 10.1001/archinternmed.2009.440
43. Ron E., Lubin J. H., Shore R. E., Mabuchi K., Modan B., Pottern L. M., Schneider A. B., Tucker M. A., Boice J. D., Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Research 1995 141 3 259 277 2-s2.0-0028963996 10.2307/3579003
44. Richardson D. B., Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology 2009 20 2 181 187 2-s2.0-66149092310 10.1097/EDE.0b013e318196ac1c
45. Memon A., Godward S., Williams D., Siddique I., Al-Saleh K., Dental x-rays and the risk of thyroid cancer: a case-control study. Acta Oncologica 2010 49 4 447 453 2-s2.0-77951212676 10.3109/02841861003705778
46. Ron E., Cancer risks from medical radiation. Health Physics 2003 85 1 47 59 2-s2.0-0038119764 10.1097/00004032-200307000-00011 (Pubitemid 36706040)
47. Franklyn J. A., Maisonneuve P., Sheppard M. C., Betteridge J., Boyle P., Mortality after the treatment of hyperthyroidism with radioactive iodine. The New England Journal of Medicine 1998 338 11 712 718 2-s2.0-0032510388 10.1056/NEJM199803123381103 (Pubitemid 28115089)
48. Metso S., Auvinen A., Huhtala H., Salmi J., Oksala H., Jaatinen P., Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer 2007 109 10 1972 1979 2-s2.0-34248341689 10.1002/cncr.22635 (Pubitemid 46744190)
49. Hieu T. T., Russell A. W., Cuneo R., Clark J., Kron T., Hall P., Doi S. A., Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis. Endocrine-Related Cancer 2012 19 5 645 655 10.1530/ERC-12-0176
50. Black P., Straaten A., Gutjahr P., Secondary thyroid carcinoma after treatment for childhood cancer. Medical and Pediatric Oncology 1998 31 2 91 95 (Pubitemid 28341022)
51. dal Maso L., Bosetti C., la Vecchia C., Franceschi S., Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes and Control 2009 20 1 75 86 2-s2.0-58249105246 10.1007/s10552-008-9219-5
52. Pellegriti G., de Vathaire F., Scollo C., Attard M., Giordano C., Arena S., Dardanoni G., Frasca F., Malandrino P., Vermiglio F., Previtera D. M., D'Azz G., Trimarchi F., Vigneri R., Papillary thyroid cancer incidence in the volcanic area of sicily. Journal of the National Cancer Institute 2009 101 22 1575 1583 2-s2.0-72949114533 10.1093/jnci/djp354
53. Feldt-Rasmussen U., Iodine and cancer. Thyroid 2001 11 5 483 486 2-s2.0-0034986755 (Pubitemid 32496288)
54. Dijkstra B., Prichard R. S., Lee A., Kelly L. M., Smyth P. P. A., Crotty T., McDermott E. W., Hill A. D. K., O'Higgins N., Changing patterns of thyroid carcinoma. Irish Journal of Medical Science 2007 176 2 87 90 2-s2.0-34250758639 10.1007/s11845-007-0041-y (Pubitemid 46952277)
55. Harach H. R., Escalante D. A., Onativia A., Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinologica 1985 108 1 55 60 2-s2.0-0021927548 (Pubitemid 15199350)
56. Guan H., Ji M., Bao R., Yu H., Wang Y., Hou P., Zhang Y., Shan Z., Teng W., Xing M. M., Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2009 94 5 1612 1617 2-s2.0-66149139313 10.1210/jc.2008-2390
57. Mazzaferri E. L., Papillary and follicular thyroid cancer: selective therapy. Comprehensive Therapy 1981 7 5 6 14 2-s2.0-0019841386 (Pubitemid 12226278)
58. Haymart M. R., Repplinger D. J., Leverson G. E., Elson D. F., Sippel R. S., Jaume J. C., Chen H., Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. Journal of Clinical Endocrinology and Metabolism 2008 93 3 809 814 2-s2.0-40849106396 10.1210/jc.2007-2215 (Pubitemid 351398557)
59. Fiore E., Rago T., Provenzale M. A., Scutari M., Ugolini C., Basolo F., Di Coscio G., Berti P., Grasso L., Elisei R., Pinchera A., Vitti P., Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocrine-Related Cancer 2009 16 4 1251 1260 2-s2.0-72549095371 10.1677/ERC-09-0036
60. Fiore E., Rago T., Provenzale M. A., Scutari M., Ugolini C., Basolo F., Di Coscio G., Miccoli P., Grasso L., Pinchera A., Vitti P., L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocrine-Related Cancer 2010 17 1 231 239 2-s2.0-77449090922 10.1677/ERC-09-0251
61. Repplinger D., Bargren A., Zhang Y. W., Adler J. T., Haymart M., Chen H., Is hashimoto's thyroiditis a risk factor for papillary thyroid cancer? Journal of Surgical Research 2008 150 1 49 52 2-s2.0-53249113227 10.1016/j.jss.2007.09. 020
62. Khatami M., Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity. Cell Biochemistry and Biophysics 2009 55 2 55 79 2-s2.0-71449114145 10.1007/s12013-009-9059-2
63. Hegedus L., Clinical practice. The thyroid nodule. The New England Journal of Medicine 2004 351 17 1764 1771 10.1056/NEJMcp031436 (Pubitemid 39383211)
64. Marqusee E., Benson C. B., Frates M. C., Doubilet P. M., Larsen P. R., Cibas E. S., Mandel S. J., Usefulness of ultrasonography in the management of nodular thyroid disease. Annals of Internal Medicine 2000 133 9 696 700 2-s2.0-0034619549
65. Cooper D. S., Doherty G. M., Haugen B. R., Kloos R. T., Lee S. L., Mandel S. J., Mazzaferri E. L., McIver B., Pacini F., Schlumberger M., Sherman S. I., Steward D. L., Tuttle R. M., Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009 19 11 1167 1214 2-s2.0-70449370231 10.1089/thy.2009.0110
66. Papini E., Guglielmi R., Bianchini A., Crescenzi A., Taccogna S., Nardi F., Panunzi C., Rinaldi R., Toscano V., Pacella C. M., Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-doppler features. Journal of Clinical Endocrinology and Metabolism 2002 87 5 1941 1946 2-s2.0-18344374873 10.1210/jc.87.5.1941 (Pubitemid 34521470)
67. Frates M. C., Benson C. B., Doubilet P. M., Kunreuther E., Contreras M., Cibas E. S., Orcutt J., Moore F. D., Larsen P. R., Marqusee E., Alexander E. K., Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. Journal of Clinical Endocrinology and Metabolism 2006 91 9 3411 3417 2-s2.0-33748743372 10.1210/jc.2006-0690 (Pubitemid 44402112)
68. Mathai V., Idikula J., Fenn A. S., Nair A., Do long-standing nodular goitres result in malignancies? Australian and New Zealand Journal of Surgery 1994 64 3 180 182 2-s2.0-0028102613 (Pubitemid 24270250)
69. Erbil Y., Barbaros U., Salmasliolu A., Mete O., Işsever H., Özarmaan S., Yilmazbayhan D., Tezelman S., Effect of thyroid gland volume in preoperative detection of suspected malignant thyroid nodules in a multinodular goiter. Archives of Surgery 2008 143 6 558 563 2-s2.0-45549090169 10.1001/archsurg.143.6.558 (Pubitemid 351860840)
70. Brito J. P., Yarur A. J., Prokop L. J., McIver B., Murad M. H., Montori V. M., Prevalence of thyroid cancer in multinodular goiter versus single nodule: a systematic review and meta-analysis. Thyroid 2013 23 4 449 455 10.1089/thy.2012.0156
71. Vigneri P., Frasca F., Sciacca L., Frittitta L., Vigneri R., Obesity and cancer. Nutrition, Metabolism and Cardiovascular Diseases 2006 16 1 1 7 2-s2.0-33646016264 10.1016/j.numecd.2005.10.013
72. Kitahara C. M., Platz E. A., Beane Freeman L. E., Hsing A. W., Linet M. S., Park Y., Schairer C., Schatzkin A., Shikany J. M., de González A. B., Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiology Biomarkers and Prevention 2011 20 3 464 472 2-s2.0-79955781856 10.1158/1055-9965.EPI-10-1220
73. Almquist M., Johansen D., Bjorge T., Ulmer H., Lindkvist B., Stocks T., Hallmans G., Engeland A., Rapp K., Jonsson H., Selmer R., Diem G., Haggstrom C., Tretli S., Stattin P., Manjer J., Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control 2011 22 5 743 751
74. Rezzónico J. N., Rezzónico M., Pusiol E., Pitoia F., Niepomniszcze H., Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metabolic Syndrome and Related Disorders 2009 7 4 375 380 2-s2.0-68549090727 10.1089/met.2008.0062
75. Mijović T., How J., Pakdaman M., Rochon L., Gologan O., Hier M. P., Black M. J., Young J., Tamilia M., Payne R. J., Body mass index in the evaluation of thyroid cancer risk. Thyroid 2009 19 5 467 472 2-s2.0-67650353920
76. Mack W. J., Preston-Martin S., Dal Maso L., Galanti R., Xiang M., Franceschi S., Hallquist A., Jin F., Kolonel L., La Vecchia C., Levi F., Linos A., Lund E., McTiernan A., Mabuchi K., Negri E., Wingren G., Ron E., A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes and Control 2003 14 8 773 785 2-s2.0-10744232003 10.1023/A:1026349702909 (Pubitemid 37463891)
77. Peterson E., De P., Nuttall R., BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One 2012 7 1 e29177
78. Kilfoy B. A., Zhang Y., Park Y., Holford T. R., Schatzkin A., Hollenbeck A., Ward M. H., Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP diet and health study. International Journal of Cancer 2011 129 1 160 172 2-s2.0-79955440764 10.1002/ijc.25650
79. Ward M. H., Kilfoy B. A., Weyer P. J., Anderson K. E., Folsom A. R., Cerhan J. R., Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 2010 21 3 389 395 2-s2.0-77950959695 10.1097/EDE.0b013e3181d6201d
80. Zhang Y., Guo G. L., Han X., Zhu C., Kilfoy B. A., Zhu Y., Boyle P., Zheng T., Do polybrominated diphenyl ethers (PBDE) increase the risk of thyroid cancer? Bioscience Hypotheses 2008 1 4 195 199 2-s2.0-52949085515 10.1016/j.bihy.2008.06.003
81. Christiani D. C., Combating environmental causes of cancer. The New England Journal of Medicine 2011 364 9 791 793 2-s2.0-79952264472 10.1056/NEJMp1006634
82. Arnbjornsson E., Arnbjornsson A., Olafsson A., Thyroid cancer incidence in relation to volcanic activity. Archives of Environmental Health 1986 41 1 36 40 2-s2.0-0022477179 (Pubitemid 16014206)
83. Kung T. M., Ng W. L., Gibson J. B., Volcanoes and carcinoma of the thyroid: a possible association. Archives of Environmental Health 1981 36 5 265 267 2-s2.0-0019454430 (Pubitemid 11026827)